Skip to main content
Peter McAllister, MD, Neurology, Stamford, CT, Milford Hospital

PeterJ.McAllisterMD

Neurology Stamford, CT

Medical Director at the New England Institute For Neurology & Headache and Assistant Professor of Internal Medicine, at The Frank H. Netter School of Medicine at Quinnipiac University

Dr. McAllister is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McAllister's full profile

Already have an account?

Education & Training

  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Neurology, 1992 - 1996
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1991 - 1992
  • Uconn School Of Medicine
    Uconn School Of MedicineClass of 1991

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1996 - 2025
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Board Member Brain Injury Alliance of Connecticut
  • Board Member Headache Cooperative of New England
  • Top Doctors: New York Metro Area Castle Connolly, 2010-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • U.S. FDA Approves QULIPTA® (Atogepant) for Adults with Chronic Migraine
    U.S. FDA Approves QULIPTA® (Atogepant) for Adults with Chronic MigraineApril 17th, 2023
  • Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., Acquires Rights to FDA-Approved ELYXYB™ in the U.S. And Canada for the Acute Treatment of Migraine
    Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., Acquires Rights to FDA-Approved ELYXYB™ in the U.S. And Canada for the Acute Treatment of MigraineFebruary 12th, 2023
  • Race, Ethnicity, and Socioeconomics Are Often Barriers to Migraine Care
    Race, Ethnicity, and Socioeconomics Are Often Barriers to Migraine CareMay 14th, 2021
  • Join now to see all

Hospital Affiliations